General Rheumatology · Monitoring
If you have a rheumatic disease, you will have blood tests fairly regularly. They do two jobs: they help show how active your condition is, and they keep an eye on your medicines to catch any effect early, while it is easy to deal with. This page explains what the common tests are for and what a result outside the usual range does and does not mean.
There are two reasons, and it helps to keep them apart. The first is to see how active your disease is, which helps your team judge whether your treatment is doing its job. The second is safety monitoring: many effective rheumatology medicines can occasionally affect the blood count, the liver, or the kidneys, and regular tests catch any change early, usually long before you would feel anything, so it can be sorted out simply.
The two you will see most often are CRP (C-reactive protein) and ESR (erythrocyte sedimentation rate, sometimes just called the "sed rate"). Both are general markers of inflammation in the body. When your disease is more active they often rise, and when it settles they often fall, so they help track your condition over time.
Two honest caveats. These markers can be normal even when you are having symptoms, so a normal result does not always mean nothing is wrong, and your team will listen to how you feel as well as read the number. And they can rise for reasons that have nothing to do with your arthritis, such as an ordinary infection, so a high result is not always a flare. Some conditions also have their own specific blood tests, such as particular antibodies, which your team will explain if they apply to you.
The exact tests depend on which medicine you take, but the common ones are easy to understand:
Checks your red cells, white cells, and platelets. Some medicines can lower these, and the count picks that up early.
Several common medicines, including methotrexate, are processed by the liver, so liver blood tests make sure it is coping.
A creatinine test shows how well your kidneys are working, which matters for how some medicines are handled and dosed.
Depending on your medicine and condition, your team may add other checks, such as a urine test or specific levels.
There is no single answer, because it depends on the medicine and how long you have been on it. As a rule, tests are more frequent when you first start or change a medicine, because that is when any effect is most likely to show, and they space out once things are settled and stable. Your team will tell you your own schedule and where to have the tests done. If you are ever unsure when your next test is due, ask, because staying on schedule is what makes monitoring work.
Results are compared against a usual range, and it is genuinely common to sit a little outside it without anything being wrong. Most of the time an unexpected result simply leads to a repeat test to see whether it was a blip, or a small adjustment to your medicine. Occasionally a medicine is paused for a short while. What matters is that these decisions are made by your team, who see the result in the context of everything else, rather than by stopping treatment yourself. If a result is important, your clinic will usually contact you; if you have been told a result and are not sure what to do, call and ask.
The most useful things you can do are simple: go for your tests when they are due, keep a copy of your results if you can, and bring any questions to your appointments. Keeping your own record can be reassuring, because it lets you see the trend rather than a single number. For some conditions our trackers can help you follow a result over time, such as the urate tracker for gout, and the symptom trackers linked from the patient guides.
This is general patient information about routine monitoring. It does not set target values or testing intervals, which depend on your specific medicines and are decided by your care team in line with current guidance. Always follow the schedule and advice your rheumatology team gives you.